描述

The global vaccine adjuvants market is set to increase by US$ 892.6 百万来自 2022 到 2028, 代表复合年增长率 (复合年增长率) 的 9.2% 在预测期内.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for vaccine adjuvants. The global vaccine adjuvants market is segmented on the basis of product, disease, 应用, 和地区. 根据产品, the global vaccine adjuvants market has been segmented into adjuvant emulsions, bacteria-derived adjuvants, carbohydrate adjuvants, liposome adjuvants, mineral salt-based adjuvant, tensoactive adjuvants, virus-like particles (VLP), 其他的. The mineral salt-based adjuvant segment held the largest revenue share in 2021. By disease, the global vaccine adjuvants market has been segmented into cancer, infectious diseases, 其他的. 在这些当中, the infectious diseases segment was accounted for the highest revenue generator in 2021. Based on application, the global vaccine adjuvants market is categorized into commercial, 研究. 从地理上来说, the global vaccine adjuvants market has been segmented into Asia Pacific, 欧洲, 北美, 世界其他地区 (排).

The global vaccine adjuvants market is highly competitive. Top players covered in Global Vaccine Adjuvants Market Study are Agenus Inc., 英国联合食品公司 (SPI Pharma Inc.), Avanti Polar Lipids Inc., Croda International plc (Brenntag Biosector A/S), CSL Limited, Dynavax Technologies Corporation, GSK plc, InvivoGen Corp., Merck & 钴. 公司, MVP Laboratories Inc. (Phibro Animal Health Corporation), Novavax Inc., OZ Biosciences SAS, Seppic SA (Air Liquide S.A.). Competitive landscape gives a description of the competitive nature of the global vaccine adjuvants market and a description of the leading companies. 确定了近年来塑造市场的关键金融交易.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the vaccine adjuvants market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

产品: adjuvant emulsions, bacteria-derived adjuvants, carbohydrate adjuvants, liposome adjuvants, mineral salt-based adjuvant, tensoactive adjuvants, virus-like particles (VLP), 其他的
Disease: cancer, infectious diseases, 其他的
应用: 商业的, 研究
地区: 亚太地区, 欧洲, 北美, 世界其他地区 (排)
考虑的年数: 本报告涵盖期间 2018 到 2028
提到的公司: Agenus Inc., 英国联合食品公司 (SPI Pharma Inc.), Avanti Polar Lipids Inc., Croda International plc (Brenntag Biosector A/S), CSL Limited, Dynavax Technologies Corporation, GSK plc, InvivoGen Corp., Merck & 钴. 公司, MVP Laboratories Inc. (Phibro Animal Health Corporation), Novavax Inc., OZ Biosciences SAS, Seppic SA (Air Liquide S.A.)

利益相关者的主要好处

– Get a comprehensive picture of the global vaccine adjuvants market
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. Vaccine adjuvants market overview
部分 3. 按产品划分的市场细分
– Adjuvant emulsions
– Bacteria-derived adjuvants
– Carbohydrate adjuvants
– Liposome adjuvants
– Mineral salt-based adjuvant
– Tensoactive adjuvants
– Virus-like particles (VLP)
– 其他的
部分 4. Market breakdown by disease
– Cancer
– Infectious diseases
– 其他的
部分 5. 按应用划分的市场细分
– 商业的
– Research
部分 6. 按地区划分的市场细分
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)
部分 7. 重点企业
– Agenus, 公司.
– 英国联合食品公司 (SPI Pharma, 公司)
– Avanti Polar Lipids, 公司.
– Croda International plc (Brenntag Biosector A/S)
– CSL Limited
– Dynavax Technologies Corporation
– GSK plc
– InvivoGen Corp.
– Merck & 公司。, 公司.
– MVP Laboratories Inc. (Phibro Animal Health Corporation)
– Novavax, 公司.
– OZ Biosciences SAS
– Seppic SA (Air Liquide S.A.)
关于StrategyHelix
免责声明